* Surgery Partners Inc SGRY.OQ SGRY.O is expected
to show a
rise in quarterly revenue when it reports results on August 6
for the period ending June 30 2024
* The Brentwood Tennessee-based company is expected to
report a
10.2% increase in revenue to $735.571 million from $667.6
million a year ago, according to the mean estimate from 10
analysts, based on LSEG data.
* LSEG's mean analyst estimate for Surgery Partners Inc is
for
earnings of 20 cents per share.
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 10 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts had fallen by
about 2.9%
in the last three months.
* Wall Street's median 12-month price target for Surgery
Partners
Inc is $38.00, above its last closing price of $30.22.
Previous quarterly performance (using preferred earnings measure
in US dollars).
QUARTER STARMINESM LSEG IBES ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT ESTIMATE MET, SE %
E® MISSED
Mar. 31 2024 0.07 0.07 0.10 Beat 39.8
Dec. 31 2024 0.38 0.38 0.44 Beat 16.2
Sep. 30 2023 0.18 0.16 0.19 Beat 16.5
Jun. 30 2023 0.09 0.08 0.28 Beat 245.3
Mar. 0.00 0.00 0.08 Beat 1,951.
31 2023 3
Dec. 31 2022 0.19 0.19 0.27 Beat 45.9
Sep. 30 2022 0.03 0.05 -0.02 Missed -143.8
Jun. 30 2022 -0.01 -0.01 -0.03 Missed -344.4
This summary was machine generated August 2 at 17:25 GMT. All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)